Record Status This is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available. Citation Eculizumab for atypical haemolytic uraemic syndrome. Barcelona: Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA). Indexing Status Subject indexing assigned by CRD MeSH Anti-Bacterial Agentss; Antibodies, Monoclonal, Humanized; Hemolytic-Uremic Syndrome Language Published Catalan Country of organisation Spain English summary An English language summary is available. Address for correspondence Antoni Parada, Catalan Agency for Health Information, Assessment and Quality (CAHIAQ). *Before: Catalan Agency for Health Technology Assessment and Research (CAHTA) Roc Boronat, 81-95 (2nd floor), 08005 Barcelona, Spain. Tel. +34 935 513 928 Fax: +34 935 517 510 Email: aparada@aatrm.catsalut.net AccessionNumber 32013000011 Date abstract record published 04/01/2013 |